HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H F Seigler Selected Research

Indicators and Reagents (Reagents)

3/2001Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H F Seigler Research Topics

Disease

6Melanoma (Melanoma, Malignant)
11/2001 - 04/2000
4Neoplasms (Cancer)
03/2001 - 04/2000
2Rectal Neoplasms (Rectal Cancer)
12/2001 - 06/2001
1Adenocarcinoma
06/2001
1Neoplasm Metastasis (Metastasis)
10/2000
1Carcinoid Tumor (Carcinoid)
10/2000
1Vaccinia
04/2000

Drug/Important Bio-Agent (IBA)

1Colloids (Colloid)IBA
11/2001
1Coloring Agents (Dyes)IBA
11/2001
1safranine T (safranin)IBA
10/2001
1Alcian BlueIBA
10/2001
1AntigensIBA
06/2001
1Lymphotoxin-alpha (Lymphotoxin)IBA
06/2001
1HLA-DR15 antigenIBA
06/2001
1HLA-DR Antigens (HLA-DR)IBA
06/2001
1fas Receptor (CD95 Antigen)IBA
06/2001
1CytokinesIBA
06/2001
1Interleukin-4 (Interleukin 4)IBA
06/2001
1Interleukin-2 (IL2)IBA
06/2001
1Cisplatin (Platino)FDA LinkGeneric
06/2001
1Fluorouracil (Carac)FDA LinkGeneric
06/2001
1Indicators and Reagents (Reagents)IBA
03/2001
1Hormones (Hormone)IBA
10/2000
1Serotonin (5 Hydroxytryptamine)IBA
10/2000
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2000
1HLA-A2 Antigen (HLA A2 Antigen)IBA
04/2000
1Peptides (Polypeptides)IBA
04/2000
1EpitopesIBA
04/2000
1HLA-A3 Antigen (HLA A3 Antigen)IBA
04/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
12/2001 - 06/2001
2Neoadjuvant Therapy
12/2001 - 06/2001
1Radiotherapy
06/2001
1Lymph Node Excision (Lymph Node Dissection)
09/2000
1Immunotherapy
04/2000